- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Hua Han Bio-Pharmaceutical Holdings Ltd
+ Add to WatchlistHUI:GR
0.211 EUR 0.001 0.48%As of 02:08:46 ET on 05/24/2013.
Snapshot for Hua Han Bio-Pharmaceutical Holdings Ltd (HUI)
| Open: | 0.211 | Day's Range: | 0.211 - 0.211 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.210 | 52wk Range: | 0.088 - 0.266 | 1-Yr Rtn: | +133.39% |
Key Statistics for HUI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | 15.1397 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (HKD) (ttm) | - |
| Est. EPS (HKD) (06/2013) | 0.1400 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 4,267 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 1.31% |
| Cash Dividend (HKD) | 0.0500 |
| Last Dividend | 01/02/2013 |
| 5 Year Dividend Growth | 54.32% |
| Next Earnings Announcement | 09/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HUI
Company Profile & Key Executives for HUI
Hua Han Bio-Pharmaceutical Holdings Limited, through its subsidiaries, researches, develops, manufactures, and sells Chinese herbal pharmaceutical products primarily for women and the elderly under its Yeosure brand name. The Company also researches, develops, manufactures, and sells naturally-sourced anti-tumor medicines and western pharmaceutical products.
| Zhang Y "Peter"Chairman/Co-Founder | Deng JieCEO/Co-Founder |
| Niu YiChief Inspector:HR | Long Xian FengExec Dir/Gen Mgr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HUI News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page